This meta-analysis reviewed 17 clinical trials to integrated different measurements and compared the expression of AR-V7 in newly diagnosed PCa and CRPC, evaluated the treatment effectiveness of first-line hormonal therapy, and estimated the prognostic value of AR-V7 in HSPC. The gene discussed is AR; the disease is posterior cortical atrophy.